On Thursday, in the course of current trade, Shares of Verso Corp (NYSE:VRS), raised 5.56%, and is now trading at $0.190.
Verso Corporation, declared the expansion of its Blazer Digital economy digital coated paper offering with 10 new sheet sizes specifically designed for the Xerox iGen4, Xerox iGen150 and new Xerox iGen 5 digital presses.
“Verso has been a leader in manufacturing digital papers since digital printing technology first emerged, with specialized expertise, dedicated production capacity and one of the broadest offerings of digital-specific products in the industry,” states Mike Weinhold, Verso’s Senior Vice President of Sales, Marketing and Product Development. “Every one of our digital products is designed specifically for digital printing.”
Verso Corporation manufactures and supplies coated papers in the United States. The company offers coated groundwood paper used for catalogs and magazines; and coated freesheet paper used primarily for annual reports, brochures, and magazine covers.
During an Afternoon trade, Shares of Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), climbed 4.15%, and is now trading at $17.82.
Aegerion Pharmaceuticals, declared that on September 1, 2015, Aegerion granted stock options to purchase an aggregate of 38,600 shares of common stock to 13 new employees under the inducement stock option program described below. Each stock option has an exercise price per share equal to $17.21, the closing price of Aegerion’s common stock on the grant date; vests 25% on the first anniversary of the date of grant with the remaining 75% to vest in monthly installments over the three years thereafter; has a ten year term; and is subject to the terms and conditions of Aegerion’s Inducement Award Stock Option Plan, and the terms and conditions of a stock option agreement covering the grant.
In January 2015, Aegerion’s Board of Directors approved the reservation of 750,000 shares of common stock to be used through the end of 2015 exclusively for the grant of non-qualified stock options to individuals who were not formerly an employee or non-employee director of Aegerion (or following a bona fide period of non-employment), as an inducement new hire stock option award material to an individual’s entry into employment within the meaning of Rule 5635(c)(4) of the NASDAQ Listing Rules (Inducement Stock Options).
Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. The company’s products comprise JUXTAPID (lomitapide) capsules, an adjunct to a low-fat diet and other lipid-lowering treatments, counting low-density lipoprotein, low-density lipoprotein cholesterol, total cholesterol, apolipoprotein B, and non-high-density lipoprotein cholesterol in adult patients with homozygous familial hypercholesterolemia (HoFH); and LOJUXTA (lomitapide) hard capsule used as a treatment for HoFH in adults.
Shares of RingCentral Inc (NYSE:RNG), dipped -0.79%, and is now trading at $18.76.
RingCentral, declared new Salesforce integration capabilities that assist customers unlock the benefits of an integrated communications experience. This integration will improvement productivity and overall efficiency of recently’s modern mobile workforce by combining CRM and business communications. With new features—counting click-to-dial and improved reporting and call logging—users can spend more time servicing clients and less time dialing.
“In 2014, 87% of businesses preferred cloud solutions over on premise solutions. As organizations move CRM applications and communications to the cloud, they have a unique opportunity to integrate the two and improve business productivity,” says Marco Casalaina, Vice President of Integrations at RingCentral.
RingCentral’s Salesforce integration will comprise improved reporting, call logging with customer fields, and new out-of-box reports. For incoming calls, RingCentral for Salesforce will automatically bring up matching records. With a simple click-to dial option from within Salesforce1, users are able to spend more time with clients instead of dialing numbers and toggling between screens.
RingCentral, Inc. provides software-as-a-service solutions for business communications primarily in the United States. The company’s products comprise RingCentral Office, a multi-location, multi-user, enterprise-grade communications solution that enables employees to communicate through voice, text, HD video and Web conferencing, and fax on devices, counting smartphones, tablets, PCs, and desk phones for businesses that require a communications solution; RingCentral Professional, an inbound call routing service with text and fax capabilities primarily for smaller businesses; and RingCentral Fax solution that provides Internet fax capabilities, which allow businesses to send and receive fax documents without the need for a fax machine
Finally, Potbelly Corp (NASDAQ:PBPB), gained 1.76% Thursday.
Potbelly Corporation, declared that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to $35 million of its common stock. Potbelly has accomplished its formerly authorized share repurchase program. The timing and volume of share repurchases will be determined by the Company’s administration based on its ongoing assessments of the capital needs of the business, the market price of its common stock and general market conditions. No time limit has been set for the completion of the repurchase program, and the program may be suspended or suspended at any time. The repurchase program authorizes the Company to purchase its common stock from time to time through open market purchases, negotiated transactions or other means, counting 10b5-1 trading plans in accordance with applicable securities laws and other restrictions.
Potbelly Corporation, through its auxiliaries, owns and operates Potbelly Sandwich Works sandwich shops in the United States. It also sells and administers franchises of new Potbelly Sandwich Works sandwich shops.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
